Merck & Co., Inc.
MRK
$125.78
$0.550.44%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -125.84% | 179.41% | -311.80% | -6.50% | -7.11% |
| Total Depreciation and Amortization | -7.67% | 11.01% | -9.18% | 11.62% | -7.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 332.24% | -101.75% | 2,282.19% | -50.84% | -22.72% |
| Change in Net Operating Assets | -93.39% | 233.07% | 43.39% | -732.85% | -231.94% |
| Cash from Operations | -96.81% | 108.34% | 176.62% | -69.77% | -20.92% |
| Capital Expenditure | -9.65% | 6.53% | 4.17% | 12.36% | -2.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -706.71% | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 83.45% | 150.22% | 1,008.00% | 95.83% | -310.18% |
| Cash from Investing | 115.87% | 97.08% | -385.08% | -34.95% | -81.70% |
| Total Debt Issued | 100.00% | -124.66% | -- | -- | -- |
| Total Debt Repaid | -200.00% | 99.94% | -174,900.00% | 0.00% | 99.90% |
| Issuance of Common Stock | -14.29% | -91.46% | 173.33% | -88.68% | 2,550.00% |
| Repurchase of Common Stock | 15.67% | -37.87% | -126.85% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.16% | 1.59% | -1.73% | -5.89% | -0.17% |
| Other Financing Activities | 70.00% | 95.73% | -188.89% | -19.12% | -294.29% |
| Cash from Financing | 47.41% | -213.60% | 282.96% | -32.18% | 42.49% |
| Foreign Exchange rate Adjustments | 218.47% | -68.82% | -206.90% | -76.23% | 188.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -159.52% | 172.58% | -36.39% | -299.93% | -2.10% |
